| 6001 | IDP dMRI ProbtrackX FA fma | GCST90003935 | 0.03 |
| 6002 | Triglycerides in large VLDL (UKB data field 23501) | GCST90269598 | 0.03 |
| 6003 | wg lh intensity-contrast parsopercularis | GCST90003809 | 0.03 |
| 6004 | ERBB4/F3 ratio | GCST90314690 | 0.03 |
| 6005 | ICD10 C53: Malignant neoplasm of cervix uteri | GCST90454202 | 0.03 |
| 6006 | APOD levels | GCST90468337 | 0.03 |
| 6007 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T196 | ECGA000196 | 0.03 |
| 6008 | CTSV levels | GCST90468917 | 0.03 |
| 6009 | PLA2G10 levels | GCST90470244 | 0.03 |
| 6010 | Diastolic blood pressure | GCST90472777 | 0.03 |
| 6011 | Total concentration of branched-chain amino acids (leucine + isoleucine + valine) | GCST90092984 | 0.03 |
| 6012 | Basal cell carcinoma | GCST90468114 | 0.03 |
| 6013 | CRADD/EDAR ratio | GCST90314235 | 0.03 |
| 6014 | Linoleic acid to total fatty acids percentage | GCST90502332 | 0.03 |
| 6015 | Cholesteryl Esters to Total Lipids in Small VLDL percentage | GCST90499800 | 0.03 |
| 6016 | WASL levels | GCST90471070 | 0.03 |
| 6017 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 42) | GCST90320861 | 0.03 |
| 6018 | aparc-DKTatlas rh volume pericalcarine | GCST90002912 | 0.03 |
| 6019 | IDP dMRI TBSS ICVF Posterior limb of internal capsule R | GCST90004345 | 0.03 |
| 6020 | Triglycerides in small HDL (UKB data field 23578) | GCST90269675 | 0.03 |
| 6021 | IDP dMRI TBSS L1 Anterior corona radiata R | GCST90004097 | 0.03 |
| 6022 | Seated height | Body size measures | UKBB00000763 | 0.03 |
| 6023 | Brainstem global volume Pons | GCST90002765 | 0.03 |
| 6024 | CSF3R levels | GCST90468885 | 0.03 |
| 6025 | INPP5J levels | GCST90469618 | 0.03 |
| 6026 | Volume of right anterior amygdaloid area | GCST90475003 | 0.03 |
| 6027 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T268 | ECGA000268 | 0.03 |
| 6028 | HBEGF levels | GCST90241392 | 0.03 |
| 6029 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T267 | ECGA000267 | 0.03 |
| 6030 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 39) | GCST90320858 | 0.03 |
| 6031 | aparc-Desikan rh area isthmuscingulate | GCST90003116 | 0.03 |
| 6032 | All influenza | FING00000064 | 0.03 |
| 6033 | Trigger finger | GCST90104907 | 0.03 |
| 6034 | PLXDC1 levels | GCST90470263 | 0.03 |
| 6035 | Androstenediol (3beta,17beta) monosulfate (1) levels | GCST90199872 | 0.03 |
| 6036 | Pelvic height | GCST90448912 | 0.03 |
| 6037 | aparc-a2009s rh area S-calcarine | GCST90003414 | 0.03 |
| 6038 | X-14626 levels | GCST90243861 | 0.03 |
| 6039 | IGSF8 levels | GCST90469540 | 0.03 |
| 6040 | ZP3 levels | GCST90471105 | 0.03 |
| 6041 | Anemia in chronic kidney disease (PheCode 285.21) | GCST90475792 | 0.03 |
| 6042 | PALM levels | GCST90470154 | 0.03 |
| 6043 | DBNL levels | GCST90468951 | 0.03 |
| 6044 | aseg global intensity 4th-Ventricle | GCST90003752 | 0.03 |
| 6045 | Valine levels (UKB data field 23467) | GCST90269564 | 0.03 |
| 6046 | SPARCL1 levels | GCST90242870 | 0.03 |
| 6047 | Whole body fat free mass (UKB data field 23101) | GCST90428120 | 0.03 |
| 6048 | Treatment or medication use - insulin product (UKB data field 20003_1140883066) | GCST90042226 | 0.03 |
| 6049 | HippSubfield rh volume Whole-hippocampal-head | GCST90002710 | 0.03 |
| 6050 | CLEC1B/PLXNA4 ratio | GCST90314100 | 0.03 |
| 6051 | Valine levels | GCST90132752 | 0.03 |
| 6052 | Provencibacterium massiliense abundance in stool | GCST90032527 | 0.03 |
| 6053 | Volume of left accessory basal nucleus | GCST90474940 | 0.03 |
| 6054 | Moderate visual impairment, binocular | FING00000831 | 0.03 |
| 6055 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 32) | GCST90320595 | 0.03 |
| 6056 | Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers) | FING00000316 | 0.03 |
| 6057 | TAX1BP3 levels | GCST90242976 | 0.03 |
| 6058 | RSPO3 levels | GCST90470504 | 0.03 |
| 6059 | TIE1 levels | GCST90470863 | 0.03 |
| 6060 | MFAP5 levels | GCST90469899 | 0.03 |
| 6061 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 30) | GCST90320849 | 0.03 |
| 6062 | DKK4/REG1B ratio | GCST90314490 | 0.03 |
| 6063 | Type 2 diabetes | GCST90086071 | 0.03 |
| 6064 | CD74/NPDC1 ratio | GCST90313895 | 0.03 |
| 6065 | IDP T1 FAST ROIs R subcallosal cortex | GCST90002504 | 0.03 |
| 6066 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T154 | ECGA000154 | 0.03 |
| 6067 | CRADD/HSPA1A ratio | GCST90314239 | 0.03 |
| 6068 | Breast cancer | neoplasms | UKBB00000109 | 0.03 |
| 6069 | Subclinical hypothyroidism in pregnancy | GCST90435197 | 0.03 |
| 6070 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T210 | ECGA000210 | 0.03 |
| 6071 | Primary gonarthrosis, bilateral | FING00001213 | 0.03 |
| 6072 | Incisional hernia (PheCode 550.6) | GCST90476064 | 0.03 |
| 6073 | Cholesterol in Small VLDL | GCST90499746 | 0.03 |
| 6074 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T166 | ECGU000166 | 0.03 |
| 6075 | Separation of retinal layers (serosa) | FING00001292 | 0.03 |
| 6076 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T271 | ECGU000271 | 0.03 |
| 6077 | Right-hemisphere salience/ventral attention network to right-hemisphere default mode network white-matter structural connectivity | GCST90302816 | 0.03 |
| 6078 | Cholesterol in Medium HDL | GCST90498495 | 0.03 |
| 6079 | Varicose veins | FING00001416 | 0.03 |
| 6080 | Systolic blood pressure | GCST90025968 | 0.03 |
| 6081 | CNTN1 levels | GCST90468803 | 0.03 |
| 6082 | TBL1X levels | GCST90470815 | 0.03 |
| 6083 | Hypertension | FING00000637 | 0.03 |
| 6084 | NUCB2/TXNDC5 ratio | GCST90315578 | 0.03 |
| 6085 | TDGF1 levels | GCST90470824 | 0.03 |
| 6086 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T209 | ECGU000209 | 0.03 |
| 6087 | Endometriosis diagnosis and infertility diagnosis occurring together | FING00000499 | 0.03 |
| 6088 | ADGRB3 levels | GCST90468234 | 0.03 |
| 6089 | FABP4 levels | GCST90012075 | 0.03 |
| 6090 | Cerebrospinal fluid S-1-pyrroline-5-carboxylate levels | GCST90318235 | 0.03 |
| 6091 | wg lh intensity-contrast lateralorbitofrontal | GCST90003803 | 0.03 |
| 6092 | CD84/F2R ratio | GCST90313912 | 0.03 |
| 6093 | GGT1/MME ratio | GCST90314930 | 0.03 |
| 6094 | Cancer of prostate (PheCode 185) | GCST90475591 | 0.03 |
| 6095 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T140 | ECGA000140 | 0.03 |
| 6096 | NPHS1 levels | GCST90470070 | 0.03 |
| 6097 | Internal derangement of knee | FING00000684 | 0.03 |
| 6098 | Macular degeneration | GCST90475386 | 0.03 |
| 6099 | DTI autoptx MD ilf r tract | GCST90385235 | 0.03 |
| 6100 | Prostate cancer | GCST90274716 | 0.03 |
| 6101 | DTI TBSS L1 Posterior thalamic radiation L | GCST90384457 | 0.03 |
| 6102 | Diabetes (standard GWA) | GCST90267278 | 0.03 |
| 6103 | IDP SWI T2star left pallidum | GCST90003869 | 0.03 |
| 6104 | Gamma glutamyl transferase levels | GCST90278630 | 0.03 |
| 6105 | aseg rh volume CerebralWhiteMatter | GCST90002632 | 0.03 |
| 6106 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T87 | ECGA000087 | 0.03 |
| 6107 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T162 | ECGA000162 | 0.03 |
| 6108 | B2M levels | GCST90468409 | 0.03 |
| 6109 | Phospholipids to total lipids ratio in small LDL | GCST90092965 | 0.03 |
| 6110 | IDP dMRI TBSS ICVF Tapetum R | GCST90004373 | 0.03 |
| 6111 | APOM/ERBB3 ratio | GCST90313314 | 0.03 |
| 6112 | Autorefraction - 3mm cylindrical power angle (left) | Eyesight | UKBB00000064 | 0.03 |
| 6113 | AHSP/CA2 ratio | GCST90313215 | 0.03 |
| 6114 | Treatment/medication code - levothyroxine sodium | Medications | UKBB00000849 | 0.03 |
| 6115 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T240 | ECGA000240 | 0.03 |
| 6116 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T157 | ECGA000157 | 0.03 |
| 6117 | Urinary ethanolamine to urinary creatinine ratio | GCST90451717 | 0.03 |
| 6118 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 47) | GCST90320866 | 0.03 |
| 6119 | Type 2 diabetes, definitions combined | FING00001382 | 0.03 |
| 6120 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T74 | ECGU000074 | 0.03 |
| 6121 | CPB2 levels | GCST90468840 | 0.03 |
| 6122 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T265 | ECGU000265 | 0.03 |
| 6123 | Mouth/teeth dental problems - Mouth ulcers | Mouth | UKBB00000488 | 0.03 |
| 6124 | Glaucoma | GCST90475383 | 0.03 |
| 6125 | Prescriptions - amlodipine | calcium channel blocker,dihydropyridine,anti-hypertensive | UKBB00000660 | 0.03 |
| 6126 | Cough on most days | Medical information | UKBB00000153 | 0.03 |
| 6127 | Excessive scarring | GCST90483368 | 0.03 |
| 6128 | Physical function (baseline) | GCST90565837 | 0.03 |
| 6129 | CEBPB/NADK ratio | GCST90314006 | 0.03 |
| 6130 | Glaucoma | GCST90475869 | 0.03 |
| 6131 | Basal cell carcinoma | GCST90013410 | 0.03 |
| 6132 | Paradoxical eczema in biologic-treated plaque psoriasis | GCST90162550 | 0.03 |
| 6133 | Cholesteryl esters to total lipids in very large HDL percentage (UKB data field 23631) | GCST90269728 | 0.03 |
| 6134 | Height, inverse-rank normalized | FING00000607 | 0.03 |
| 6135 | SUMF1 levels | GCST90470783 | 0.03 |
| 6136 | Peripheral vascular disease | GCST90086134 | 0.03 |
| 6137 | Operation code - carpal tunnel surgery | Operations | UKBB00000553 | 0.03 |
| 6138 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T161 | ECGA000161 | 0.03 |
| 6139 | aparc-a2009s lh thickness S-cingul-Marginalis | GCST90003648 | 0.03 |
| 6140 | NPC2 levels | GCST90470068 | 0.03 |
| 6141 | ADAMTS15/SULT2A1 ratio | GCST90313171 | 0.03 |
| 6142 | Phospholipids in large VLDL (UKB data field 23497) | GCST90269594 | 0.03 |
| 6143 | DLL1/IL18BP ratio | GCST90314495 | 0.03 |
| 6144 | DAG1/GP6 ratio | GCST90314375 | 0.03 |
| 6145 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T254 | ECGU000254 | 0.03 |
| 6146 | IDP dMRI TBSS L2 Pontine crossing tract | GCST90004124 | 0.03 |
| 6147 | IDP dMRI ProbtrackX ISOVF ilf l | GCST90004539 | 0.03 |
| 6148 | Osteitis deformans and osteopathies associated with other disorders classified elsewhere (PheCode 731) | GCST90476246 | 0.03 |
| 6149 | IL10 levels | GCST90469546 | 0.03 |
| 6150 | Right-hemisphere visual network to hippocampus white-matter structural connectivity | GCST90302785 | 0.03 |
| 6151 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T252 | ECGA000252 | 0.03 |
| 6152 | MAP3K5 levels | GCST90469854 | 0.03 |
| 6153 | IDP dMRI TBSS ISOVF Posterior thalamic radiation R | GCST90004505 | 0.03 |
| 6154 | ESM1 levels | GCST90012068 | 0.03 |
| 6155 | BCAN/KLK6 ratio | GCST90313479 | 0.03 |
| 6156 | SERPINB6 levels | GCST90470591 | 0.03 |
| 6157 | Androstenediol (3beta,17beta) disulfate (2) levels | GCST90199851 | 0.03 |
| 6158 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 10) | GCST90320829 | 0.03 |
| 6159 | Average diameter for VLDL particles (UKB data field 23431) | GCST90269528 | 0.03 |
| 6160 | Right-hemisphere visual network to caudate white-matter structural connectivity | GCST90302782 | 0.03 |
| 6161 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T270 | ECGA000270 | 0.03 |
| 6162 | aparc-DKTatlas rh area lateraloccipital | GCST90003274 | 0.03 |
| 6163 | Interpolated Year when non-cancer illness first diagnosed | Medical conditions | UKBB00000371 | 0.03 |
| 6164 | Volume of left paralaminar nucleus | GCST90474982 | 0.03 |
| 6165 | aparc-DKTatlas rh area pericalcarine | GCST90003284 | 0.03 |
| 6166 | Mean corpuscular haemoglobin | Blood count | UKBB00000447 | 0.03 |
| 6167 | Diastolic blood pressure | GCST90472779 | 0.03 |
| 6168 | Acute pancreatitis | GCST90018569 | 0.03 |
| 6169 | Cholesteryl esters in large VLDL (UKB data field 23499) | GCST90269596 | 0.03 |
| 6170 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T160 | ECGA000160 | 0.03 |
| 6171 | Phenylacetylcarnitine levels | GCST90199993 | 0.03 |
| 6172 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T441 | ECGU000441 | 0.03 |
| 6173 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 14) | GCST90320577 | 0.03 |
| 6174 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T23 | ECGA000023 | 0.03 |
| 6175 | Diabetes mellitus | endocrine/metabolic | UKBB00000169 | 0.03 |
| 6176 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 34) | GCST90320597 | 0.03 |
| 6177 | Modified Stumvoll Insulin Sensitivity Index | GCST90267574 | 0.03 |
| 6178 | T1 FreeSurfer a2009s rh G cuneus area | GCST90384900 | 0.03 |
| 6179 | Otitis media and Eustachian tube disorders (PheCode 381) | GCST90475902 | 0.03 |
| 6180 | Left-hemisphere default mode network to amygdala white-matter structural connectivity | GCST90302772 | 0.03 |
| 6181 | Height (baseline) | GCST90565843 | 0.03 |
| 6182 | Sphingomyelin (d18:1/16:0) levels | GCST90025744 | 0.03 |
| 6183 | Exophthalmic conditions | FING00000526 | 0.03 |
| 6184 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T266 | ECGA000266 | 0.03 |
| 6185 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T161 | ECGU000161 | 0.03 |
| 6186 | LGALS4/PCDH17 ratio | GCST90315315 | 0.03 |
| 6187 | IDP dMRI TBSS L2 Uncinate fasciculus R | GCST90004167 | 0.03 |
| 6188 | Peak expiratory flow (PEF) | Spirometry | UKBB00000638 | 0.03 |
| 6189 | GRAP2/PLPBP ratio | GCST90314984 | 0.03 |
| 6190 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T242 | ECGA000242 | 0.03 |
| 6191 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T146 | ECGA000146 | 0.03 |
| 6192 | Lichen sclerosus et atrophicus | FING00000723 | 0.03 |
| 6193 | REST UKBBICA NET100 1287 | GCST90387141 | 0.03 |
| 6194 | Colonic or urogenital fistula | FING00000315 | 0.03 |
| 6195 | ICD10 O24.4: Diabetes mellitus arising in pregnancy | GCST90454236 | 0.03 |
| 6196 | eGFR in diabetes mellitus (loose) kidney healthy controls (minimal adjustment) | GCST90624778 | 0.03 |
| 6197 | IDP dMRI TBSS ISOVF Sagittal stratum R | GCST90004507 | 0.03 |
| 6198 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T158 | ECGU000158 | 0.03 |
| 6199 | Volume of right medial nucleus | GCST90475042 | 0.03 |
| 6200 | RAPGEF2 levels | GCST90470426 | 0.03 |
| 6201 | Colon cancer (PheCode 153.2) | GCST90475567 | 0.03 |
| 6202 | CASP8 levels | GCST90468548 | 0.03 |
| 6203 | magnesium (Mg, maximum, inv-norm transformed) | GCST90475477 | 0.03 |
| 6204 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T144 | ECGU000144 | 0.03 |
| 6205 | Height | GCST90302890 | 0.03 |
| 6206 | Maternal care for other conditions predominantly related to pregnancy | FING00000791 | 0.03 |
| 6207 | Conjunctivitis | FING00000346 | 0.03 |
| 6208 | CALCOCO1/DCTN1 ratio | GCST90313600 | 0.03 |
| 6209 | Femur length to body height ratio | GCST90270256 | 0.03 |
| 6210 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 8) | GCST90320827 | 0.03 |
| 6211 | TRIM24 levels | GCST90470965 | 0.03 |
| 6212 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T168 | ECGA000168 | 0.03 |
| 6213 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T460 | ECGU000460 | 0.03 |
| 6214 | Levulinate 4-oxovalerate levels | GCST90243545 | 0.03 |
| 6215 | Triglycerides in very large VLDL | GCST90500671 | 0.03 |
| 6216 | Cholesteryl esters to total lipids ratio in small VLDL | GCST90092971 | 0.03 |
| 6217 | aparc-Desikan rh volume parsopercularis | GCST90002818 | 0.03 |
| 6218 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T139 | ECGA000139 | 0.03 |
| 6219 | Other (seronegative) rheumatoid arthritis, wide | FING00000917 | 0.03 |
| 6220 | BAX levels | GCST90468424 | 0.03 |
| 6221 | ENPP7 levels | GCST90469118 | 0.03 |
| 6222 | ERBB4/UMOD ratio | GCST90314692 | 0.03 |
| 6223 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T195 | ECGA000195 | 0.03 |
| 6224 | Medication use (salicylic acid and derivatives) | GCST90018775 | 0.03 |
| 6225 | Hyperplasia of prostate (PheCode 600) | GCST90476153 | 0.03 |
| 6226 | FCRL2/SEMA7A ratio | GCST90314800 | 0.03 |
| 6227 | Alanine levels | GCST90092806 | 0.03 |
| 6228 | GLOD4/S100A4 ratio | GCST90314944 | 0.03 |
| 6229 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T433 | ECGU000433 | 0.03 |
| 6230 | LACRT levels | GCST90469725 | 0.03 |
| 6231 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T116 | ECGU000116 | 0.03 |
| 6232 | Free cholesterol to total lipids in small LDL percentage (UKB data field 23627) | GCST90269724 | 0.03 |
| 6233 | HBEGF/PLXNA4 ratio | GCST90315036 | 0.03 |
| 6234 | Eosinophil count | GCST90018733 | 0.03 |
| 6235 | CFB levels | GCST90468723 | 0.03 |
| 6236 | RHOC levels | GCST90470467 | 0.03 |
| 6237 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T147 | ECGA000147 | 0.03 |
| 6238 | Volume of right central nucleus | GCST90474916 | 0.03 |
| 6239 | Valine levels | GCST90092995 | 0.03 |
| 6240 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T270 | ECGU000270 | 0.03 |
| 6241 | MAPK9 levels | GCST90469857 | 0.02 |
| 6242 | CRTAM/GZMA ratio | GCST90314275 | 0.02 |
| 6243 | CWC15 levels | GCST90468920 | 0.02 |
| 6244 | rfMRI connectivity ICA-features 4 | GCST90006342 | 0.02 |
| 6245 | Volume of right whole amygdala | GCST90474931 | 0.02 |
| 6246 | hemoglobin (mean, inv-norm transformed) | GCST90475374 | 0.02 |
| 6247 | KCTD5 levels | GCST90469670 | 0.02 |
| 6248 | Triglycerides in very small VLDL | GCST90500885 | 0.02 |
| 6249 | ICA1/MVK ratio | GCST90315108 | 0.02 |
| 6250 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T215 | ECGU000215 | 0.02 |
| 6251 | COL6A3 levels | GCST90468821 | 0.02 |
| 6252 | TNFRSF4/TNFRSF9 ratio | GCST90315939 | 0.02 |
| 6253 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T17 | ECGA000017 | 0.02 |
| 6254 | CX3CL1 levels | GCST90241204 | 0.02 |
| 6255 | S100A12 levels | GCST90470513 | 0.02 |
| 6256 | Left-hemisphere somatomotor network to thalamus white-matter structural connectivity | GCST90302682 | 0.02 |
| 6257 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T273 | ECGU000273 | 0.02 |
| 6258 | GP2/LGALS4 ratio | GCST90314960 | 0.02 |
| 6259 | VWC2L levels | GCST90471063 | 0.02 |
| 6260 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T159 | ECGA000159 | 0.02 |
| 6261 | Age-related macular degeneration (whether dry or wet) | FING00000047 | 0.02 |
| 6262 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T178 | ECGU000178 | 0.02 |
| 6263 | Left-hemisphere limbic network to putamen white-matter structural connectivity | GCST90302738 | 0.02 |
| 6264 | SUMF2 levels | GCST90470784 | 0.02 |
| 6265 | Autorefraction - 3mm weak meridian angle (left) | Eyesight | UKBB00000071 | 0.02 |
| 6266 | aparc-a2009s lh volume G-cingul-Post-ventral | GCST90002934 | 0.02 |
| 6267 | Omega-3 fatty acids to total fatty acids percentage | GCST90502090 | 0.02 |
| 6268 | X-23641 levels | GCST90200603 | 0.02 |
| 6269 | BST1 levels | GCST90468474 | 0.02 |
| 6270 | LY6D/NECTIN4 ratio | GCST90315344 | 0.02 |
| 6271 | Breast cancer (PheCode 174) | GCST90435600 | 0.02 |
| 6272 | ALB levels | GCST90269576 | 0.02 |
| 6273 | PIK3IP1/TNFRSF1B ratio | GCST90315654 | 0.02 |
| 6274 | CRELD1 levels | GCST90468858 | 0.02 |
| 6275 | ADH4/DCXR ratio | GCST90313190 | 0.02 |
| 6276 | CD302/CD99 ratio | GCST90313805 | 0.02 |
| 6277 | AGXT/MME ratio | GCST90313207 | 0.02 |
| 6278 | Prevotella sp000434975 abundance in stool | GCST90032518 | 0.02 |
| 6279 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T253 | ECGA000253 | 0.02 |
| 6280 | PENK levels | GCST90470208 | 0.02 |
| 6281 | Osteoporosis | GCST90468145 | 0.02 |
| 6282 | Thyroid problems | GCST90475276 | 0.02 |
| 6283 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T13 | ECGU000013 | 0.02 |
| 6284 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T209 | ECGA000209 | 0.02 |
| 6285 | ACYP2 levels | GCST90240187 | 0.02 |
| 6286 | total creatine kinase (minimum, inv-norm transformed) | GCST90476416 | 0.02 |
| 6287 | BCAT1 levels | GCST90468427 | 0.02 |
| 6288 | First line medication for Crohn's disease | FING00000544 | 0.02 |
| 6289 | CST3/RETN ratio | GCST90314297 | 0.02 |
| 6290 | Disorders of choroid and retina | FING00000438 | 0.02 |
| 6291 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T142 | ECGA000142 | 0.02 |
| 6292 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T212 | ECGA000212 | 0.02 |
| 6293 | IDP T1 FAST ROIs L planum temporale | GCST90002541 | 0.02 |
| 6294 | Ankle spacing width | Bone-densitometry of heel | UKBB00000035 | 0.02 |
| 6295 | T1 FreeSurfer BA rh V2 exvivo area | GCST90385557 | 0.02 |
| 6296 | aparc-Desikan lh volume lingual | GCST90002780 | 0.02 |
| 6297 | Right-hemisphere limbic network to caudate white-matter structural connectivity | GCST90302828 | 0.02 |
| 6298 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T243 | ECGA000243 | 0.02 |
| 6299 | Prostate cancer | GCST90011808 | 0.02 |
| 6300 | Left-hemisphere control network to amygdala white-matter structural connectivity | GCST90302757 | 0.02 |
| 6301 | Osteopathies and chondropathies | FING00000913 | 0.02 |
| 6302 | ThalamNuclei lh volume VAmc | GCST90002723 | 0.02 |
| 6303 | IPCEF1/SPARC ratio | GCST90315186 | 0.02 |
| 6304 | LPO levels | GCST90469789 | 0.02 |
| 6305 | wg lh intensity-contrast insula | GCST90003826 | 0.02 |
| 6306 | N6,N6-dimethyllysine levels in chronic kidney disease | GCST90257529 | 0.02 |
| 6307 | Total lipids in large HDL (UKB data field 23559) | GCST90269656 | 0.02 |
| 6308 | CPM levels | GCST90468843 | 0.02 |
| 6309 | Cyst of kidney, acquired (PheCode 586.2) | GCST90476133 | 0.02 |
| 6310 | LAT/PLXNA4 ratio | GCST90315286 | 0.02 |
| 6311 | Volume of right central nucleus | GCST90475027 | 0.02 |
| 6312 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 4) | GCST90320567 | 0.02 |
| 6313 | GLRX5 levels | GCST90469361 | 0.02 |
| 6314 | CCL5/TACC3 ratio | GCST90313707 | 0.02 |
| 6315 | Standing height (UKB data field 50) | GCST90468178 | 0.02 |
| 6316 | ENO2/TXNDC5 ratio | GCST90314671 | 0.02 |
| 6317 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T434 | ECGU000434 | 0.02 |
| 6318 | SPINK6 levels | GCST90470725 | 0.02 |
| 6319 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T68 | ECGU000068 | 0.02 |
| 6320 | IDP dMRI TBSS L2 External capsule R | GCST90004155 | 0.02 |
| 6321 | MGLL/PLA2G4A ratio | GCST90315439 | 0.02 |
| 6322 | ICD10 C61: Malignant neoplasm of prostate | GCST90043894 | 0.02 |
| 6323 | AXIN1/INPPL1 ratio | GCST90313410 | 0.02 |
| 6324 | aparc-Desikan rh volume insula | GCST90002834 | 0.02 |
| 6325 | Otitis media (PheCode 381.1) | GCST90475903 | 0.02 |
| 6326 | LMNB2 levels | GCST90469782 | 0.02 |
| 6327 | Medication use (vasodilators used in cardiac diseases) | GCST90018763 | 0.02 |
| 6328 | Standing height | Body size measures | UKBB00000796 | 0.02 |
| 6329 | Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers) | FING00000755 | 0.02 |
| 6330 | COCH levels | GCST90468810 | 0.02 |
| 6331 | Citrate levels (UKB data field 23473) | GCST90269570 | 0.02 |
| 6332 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T176 | ECGU000176 | 0.02 |
| 6333 | CD244/FCRL6 ratio | GCST90313765 | 0.02 |
| 6334 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 83) | GCST90320902 | 0.02 |
| 6335 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T205 | ECGA000205 | 0.02 |
| 6336 | T1 FreeSurfer DK rh lateraloccipital area | GCST90385699 | 0.02 |
| 6337 | Total triglycerides levels (UKB data field 23407) | GCST90269504 | 0.02 |
| 6338 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T154 | ECGU000154 | 0.02 |
| 6339 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T22 | ECGA000022 | 0.02 |
| 6340 | CLEC1B/MGLL ratio | GCST90314097 | 0.02 |
| 6341 | Phospholipids in small LDL | GCST90499681 | 0.02 |
| 6342 | Ascending aorta diameter | GCST90267390 | 0.02 |
| 6343 | ThalamNuclei lh volume VPL | GCST90002717 | 0.02 |
| 6344 | DTI autoptx L1 cst r tract | GCST90385148 | 0.02 |
| 6345 | IGLC2 levels | GCST90469536 | 0.02 |
| 6346 | Cancer of urinary organs (incl. kidney and bladder) (PheCode 189) | GCST90475593 | 0.02 |
| 6347 | QC SWI-to-T1 linear alignment discrepancy | GCST90006352 | 0.02 |
| 6348 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T255 | ECGA000255 | 0.02 |
| 6349 | IL22 levels | GCST90088066 | 0.02 |
| 6350 | DTI autoptx MD ifo r tract | GCST90385233 | 0.02 |
| 6351 | ABHD14B/SPARC ratio | GCST90313146 | 0.02 |
| 6352 | Operation code - bunion/hallus valgus surgery | Operations | UKBB00000551 | 0.02 |
| 6353 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T10 | ECGU000010 | 0.02 |
| 6354 | EIF4G1/HEXIM1 ratio | GCST90314635 | 0.02 |
| 6355 | ADGRG2 levels | GCST90468241 | 0.02 |
| 6356 | Bicarbonate (mean, inv-norm transformed) | GCST90475148 | 0.02 |
| 6357 | ThalamNuclei rh volume VAmc | GCST90002747 | 0.02 |
| 6358 | Total lipids in medium VLDL (UKB data field 23503) | GCST90269600 | 0.02 |
| 6359 | aseg global volume Brain-Stem | GCST90002602 | 0.02 |
| 6360 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T25 | ECGA000025 | 0.02 |
| 6361 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T141 | ECGA000141 | 0.02 |
| 6362 | severe traumatic brain injury, does not include concussion | FING00001300 | 0.02 |
| 6363 | aparc-pial rh area pericalcarine | GCST90003194 | 0.02 |
| 6364 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T272 | ECGU000272 | 0.02 |
| 6365 | Type 1 diabetes | GCST90018705 | 0.02 |
| 6366 | CKAP4/IL4R ratio | GCST90314072 | 0.02 |
| 6367 | Arthrosis | FING00000111 | 0.02 |
| 6368 | PNLIPRP1 levels | GCST90470273 | 0.02 |
| 6369 | ELOA/MAD1L1 ratio | GCST90314640 | 0.02 |
| 6370 | Concentration of very large VLDL particles (UKB data field 23488) | GCST90269585 | 0.02 |
| 6371 | TNFRSF11B levels | GCST90470903 | 0.02 |
| 6372 | Phenylacetylglutamate levels | GCST90200069 | 0.02 |
| 6373 | CETN3 levels | GCST90468722 | 0.02 |
| 6374 | IDP dMRI TBSS OD Superior corona radiata R | GCST90004426 | 0.02 |
| 6375 | Total lipids in very large VLDL (UKB data field 23489) | GCST90269586 | 0.02 |
| 6376 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T182 | ECGU000182 | 0.02 |
| 6377 | HSPB1 levels | GCST90179317 | 0.02 |
| 6378 | DAG1/PLA2G4A ratio | GCST90314380 | 0.02 |
| 6379 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T138 | ECGA000138 | 0.02 |
| 6380 | SLC5A8 levels | GCST90242850 | 0.02 |
| 6381 | DFFA/SIRT2 ratio | GCST90314462 | 0.02 |
| 6382 | BA-exvivo rh area V1 | GCST90003230 | 0.02 |
| 6383 | Triglycerides in very large VLDL (UKB data field 23494) | GCST90269591 | 0.02 |
| 6384 | STK11/USP8 ratio | GCST90315892 | 0.02 |
| 6385 | Birth size (multivariate analysis) | GCST90624101 | 0.02 |
| 6386 | ARHGAP1/SPARC ratio | GCST90313344 | 0.02 |
| 6387 | FGF19/SCG2 ratio | GCST90314809 | 0.02 |
| 6388 | Skin cancer | GCST90475189 | 0.02 |
| 6389 | Omega-3 fatty acid levels | GCST90502424 | 0.02 |
| 6390 | ICD10 O42: Premature rupture of membranes | GCST90454238 | 0.02 |
| 6391 | Body size (confirmatory factor analysis Factor 21) | GCST90309355 | 0.02 |
| 6392 | X-21441 levels | GCST90200581 | 0.02 |
| 6393 | CNTNAP2/DPP10 ratio | GCST90314167 | 0.02 |
| 6394 | ICAM2/IL7R ratio | GCST90315117 | 0.02 |
| 6395 | TNXB levels | GCST90470930 | 0.02 |
| 6396 | ACHE levels | GCST90468199 | 0.02 |
| 6397 | Impacted cerumen (PheCode 380.4) | GCST90475901 | 0.02 |
| 6398 | Brainstem global volume Whole-brainstem | GCST90002768 | 0.02 |
| 6399 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T267 | ECGU000267 | 0.02 |
| 6400 | DBNL/PDGFB ratio | GCST90314422 | 0.02 |
| 6401 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T12 | ECGA000012 | 0.02 |
| 6402 | Medication for pain relief, constipation, heartburn - Laxatives (e.g. Dulcolax, Senokot) | Medication | UKBB00000456 | 0.02 |
| 6403 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T35 | ECGA000035 | 0.02 |
| 6404 | Height | GCST90278637 | 0.02 |
| 6405 | SPINT1/SUSD2 ratio | GCST90315878 | 0.02 |
| 6406 | Hydrocele (PheCode 603.1) | GCST90476157 | 0.02 |
| 6407 | Diverticulosis and diverticulitis (PheCode 562) | GCST90476073 | 0.02 |
| 6408 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T177 | ECGU000177 | 0.02 |
| 6409 | Eye problems/disorders - None of the above | Eyesight | UKBB00000232 | 0.02 |
| 6410 | CCDC50 levels | GCST90468561 | 0.02 |
| 6411 | PPCDC/RWDD1 ratio | GCST90315704 | 0.02 |
| 6412 | Cholesteryl esters in very large VLDL (UKB data field 23492) | GCST90269589 | 0.02 |
| 6413 | HLA-DRA levels | GCST90469458 | 0.02 |
| 6414 | Diaphragmatic hernia (PheCode 550.2) | GCST90476061 | 0.02 |
| 6415 | Spermatocele (PheCode 603.2) | GCST90476158 | 0.02 |
| 6416 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T158 | ECGA000158 | 0.02 |
| 6417 | Takes medication for Thyroid problems? | GCST90475277 | 0.02 |
| 6418 | CPB1/CTRC ratio | GCST90314209 | 0.02 |
| 6419 | BLNK levels | GCST90468448 | 0.02 |
| 6420 | Cholecystectomy | FING00000273 | 0.02 |
| 6421 | Left-hemisphere visual network to left-hemisphere control network white-matter structural connectivity | GCST90302653 | 0.02 |
| 6422 | Sleep disorders | neurological | UKBB00000776 | 0.02 |
| 6423 | Forced expiratory volume (baseline) | GCST90565844 | 0.02 |
| 6424 | aparc-DKTatlas lh volume lingual | GCST90002873 | 0.02 |
| 6425 | CTBS levels | GCST90468900 | 0.02 |
| 6426 | Coxarthrosis, primary, with hip surgery | FING00000364 | 0.02 |
| 6427 | Total body bone mineral density (age 45-60) | GCST005350 | 0.02 |
| 6428 | GUCA2A/LGALS4 ratio | GCST90314998 | 0.02 |
| 6429 | CLPP/DECR1 ratio | GCST90314137 | 0.02 |
| 6430 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T239 | ECGU000239 | 0.02 |
| 6431 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T498 | ECGA000498 | 0.02 |
| 6432 | HBEGF/WWP2 ratio | GCST90315038 | 0.02 |
| 6433 | IDP dMRI TBSS ICVF Uncinate fasciculus R | GCST90004371 | 0.02 |
| 6434 | UCMA levels | GCST90243285 | 0.02 |
| 6435 | DVT of lower extremities | FING00000482 | 0.02 |
| 6436 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T190 | ECGA000190 | 0.02 |
| 6437 | PIK3IP1/TNFRSF1A ratio | GCST90315653 | 0.02 |
| 6438 | Urine GlcNAc sulfate conjugate of C21H34O2 steroid** levels in chronic kidney disease | GCST90265175 | 0.02 |
| 6439 | DAB2/LYN ratio | GCST90314365 | 0.02 |
| 6440 | ESAM/SCARF1 ratio | GCST90314715 | 0.02 |
| 6441 | LPO levels | GCST90241730 | 0.02 |
| 6442 | aparc-DKTatlas lh area fusiform | GCST90003239 | 0.02 |
| 6443 | CLEC14A/PTPRS ratio | GCST90314081 | 0.02 |
| 6444 | T1 FreeSurfer DK lh MeanThickness thickness | GCST90385656 | 0.02 |
| 6445 | ALDH1A1 levels | GCST90468280 | 0.02 |
| 6446 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T254 | ECGA000254 | 0.02 |
| 6447 | PLXNB2/SEMA7A ratio | GCST90315692 | 0.02 |
| 6448 | CFHR4 levels | GCST90468727 | 0.02 |
| 6449 | PAPPA levels | GCST90012036 | 0.02 |
| 6450 | IGF1 levels | GCST90025989 | 0.02 |
| 6451 | Glycosyl ceramide (d18:2/24:1, d18:1/24:2) levels | GCST90200118 | 0.02 |
| 6452 | THTPA levels | GCST90470860 | 0.02 |
| 6453 | Non-cancer illness code, self-reported - migraine | Medical conditions | UKBB00000520 | 0.02 |
| 6454 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T442 | ECGU000442 | 0.02 |
| 6455 | FUT8/RSPO1 ratio | GCST90314891 | 0.02 |
| 6456 | HYAL1 levels | GCST90469495 | 0.02 |
| 6457 | RGMA/RGMB ratio | GCST90315769 | 0.02 |
| 6458 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T6 | ECGU000006 | 0.02 |
| 6459 | Aneurysms, operations, SAH | FING00000085 | 0.02 |
| 6460 | DTI TBSS MD Tapetum L | GCST90384619 | 0.02 |
| 6461 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 26) | GCST90320589 | 0.02 |
| 6462 | Urine glycocholenate sulfate* levels in chronic kidney disease | GCST90265292 | 0.02 |
| 6463 | FLT1 levels | GCST90469249 | 0.02 |
| 6464 | Asthma (only as main-diagnosis) (more control exclusions) | FING00000114 | 0.02 |
| 6465 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T16 | ECGA000016 | 0.02 |
| 6466 | PSTPIP2 levels | GCST90470366 | 0.02 |
| 6467 | HYOU1/THBD ratio | GCST90315106 | 0.02 |
| 6468 | Total bilirubin levels (UKB data field 30840) | GCST90468104 | 0.02 |
| 6469 | LAMB1 levels | GCST90469732 | 0.02 |
| 6470 | PNLIPRP2 levels | GCST90470274 | 0.02 |
| 6471 | Use of disulfiram, acamprosate or naltrexone | FING00001410 | 0.02 |
| 6472 | IL18BP/THBD ratio | GCST90315156 | 0.02 |
| 6473 | CPA1/PRSS2 ratio | GCST90314206 | 0.02 |
| 6474 | Cholesteryl Esters to Total Lipids in Small HDL percentage | GCST90499406 | 0.02 |
| 6475 | Skin elastin (cheek, R5) | GCST90502787 | 0.02 |
| 6476 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T72 | ECGU000072 | 0.02 |
| 6477 | wg lh intensity-contrast inferiortemporal | GCST90003800 | 0.02 |
| 6478 | Sleep disorders | Episodic and paroxysmal disorders | UKBB00000775 | 0.02 |
| 6479 | PRSS2 levels | GCST90243126 | 0.02 |
| 6480 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T24 | ECGA000024 | 0.02 |
| 6481 | Volume of right basal nucleus | GCST90474910 | 0.02 |
| 6482 | Triglyceride levels (MTAG) | GCST90179149 | 0.02 |
| 6483 | DTI autoptx L1 atr l tract | GCST90385141 | 0.02 |
| 6484 | Non-cancer illness code, self-reported - glaucoma | Medical conditions | UKBB00000511 | 0.02 |
| 6485 | Free cholesterol in medium LDL | GCST90498767 | 0.02 |
| 6486 | LSIL lesion of the cervix uteri, vagina or vulva | FING00000733 | 0.02 |
| 6487 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T208 | ECGU000208 | 0.02 |
| 6488 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T150 | ECGU000150 | 0.02 |
| 6489 | ADGRE5/GAS6 ratio | GCST90313179 | 0.02 |
| 6490 | Right-hemisphere default mode network to caudate white-matter structural connectivity | GCST90302845 | 0.02 |
| 6491 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T264 | ECGU000264 | 0.02 |
| 6492 | Triglyceride to HDL cholesterol ratio | GCST90295950 | 0.02 |
| 6493 | Inguinal hernia, bilateral | FING00000682 | 0.02 |
| 6494 | PSPN levels | GCST90470364 | 0.02 |
| 6495 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T42 | ECGA000042 | 0.02 |
| 6496 | Mean sphered cell volume | Blood count | UKBB00000452 | 0.02 |
| 6497 | BCAN/CD200 ratio | GCST90313477 | 0.02 |
| 6498 | IL1R2 levels | GCST90469572 | 0.02 |
| 6499 | Pure hyperglyceridaemia | FING00001231 | 0.02 |
| 6500 | IL17RB levels | GCST90469563 | 0.02 |
| 6501 | IL4R levels | GCST90469598 | 0.02 |
| 6502 | EFNA4/VWC2 ratio | GCST90314607 | 0.02 |
| 6503 | Alpha angle | GCST90129635 | 0.02 |
| 6504 | LDL cholesterol | GCST90018741 | 0.02 |
| 6505 | aparc-DKTatlas rh volume cuneus | GCST90002896 | 0.02 |
| 6506 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T14 | ECGU000014 | 0.02 |
| 6507 | BSG/LY9 ratio | GCST90313534 | 0.02 |
| 6508 | CXCL11/CXCL13 ratio | GCST90314333 | 0.02 |
| 6509 | Glucosamine medication | FING00000584 | 0.02 |
| 6510 | ACAA1 levels | GCST90468193 | 0.02 |
| 6511 | SRPX levels | GCST90470744 | 0.02 |
| 6512 | TNFSF10 levels | GCST90012011 | 0.02 |
| 6513 | T1 CAT volume L VIIIb | GCST90384130 | 0.02 |
| 6514 | FEV1 | GCST007432 | 0.02 |
| 6515 | Tachycardia NOS (PheCode 427.7) | GCST90475979 | 0.02 |
| 6516 | 1,5-anhydroglucitol (1,5-ag) levels | GCST90243529 | 0.02 |
| 6517 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T207 | ECGA000207 | 0.02 |
| 6518 | Hand grip strength (right) | Hand grip strength | UKBB00000301 | 0.02 |
| 6519 | Pregnenetriol disulfate levels | GCST90200238 | 0.02 |
| 6520 | aparc-Desikan rh volume lateraloccipital | GCST90002811 | 0.02 |
| 6521 | FCRL2/TNFRSF13B ratio | GCST90314801 | 0.02 |
| 6522 | Eosinophil count variance | GCST90565689 | 0.02 |
| 6523 | TFF1 levels | GCST90470835 | 0.02 |
| 6524 | Operation code - varicose vein surgery | Operations | UKBB00000568 | 0.02 |
| 6525 | Pulse pressure (BMI unadjusted) | GCST90335166 | 0.02 |
| 6526 | Hair colour (natural, before greying) - Blonde | Sun exposure | UKBB00000296 | 0.02 |
| 6527 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T500 | ECGA000500 | 0.02 |
| 6528 | Cholesteryl Esters in Medium HDL | GCST90498532 | 0.02 |
| 6529 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 64) | GCST90320627 | 0.02 |
| 6530 | wg lh intensity-contrast bankssts | GCST90003793 | 0.02 |
| 6531 | Anti-human herpes virus 6 IE1A IgG seropositivity | GCST90006903 | 0.02 |
| 6532 | Venous thromboembolism | FING00001427 | 0.02 |
| 6533 | Disorders of muscle, ligament, and fascia | musculoskeletal | UKBB00000187 | 0.02 |
| 6534 | TDRKH levels | GCST90470827 | 0.02 |
| 6535 | CXCL10/CXCL11 ratio | GCST90314330 | 0.02 |
| 6536 | EGLN1/PSIP1 ratio | GCST90314620 | 0.02 |
| 6537 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T198 | ECGA000198 | 0.02 |
| 6538 | REN levels | GCST90012038 | 0.02 |
| 6539 | Type 2 diabetes | endocrine/metabolic | UKBB00000867 | 0.02 |
| 6540 | CCN2/SPINT2 ratio | GCST90313716 | 0.02 |
| 6541 | Haemorrhoids and perianal venous thrombosis | FING00000599 | 0.02 |
| 6542 | aparc-Desikan rh volume pericalcarine | GCST90002821 | 0.02 |
| 6543 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T69 | ECGU000069 | 0.02 |
| 6544 | Retinal detachments and breaks | FING00001260 | 0.02 |
| 6545 | wg rh intensity-contrast inferiortemporal | GCST90003835 | 0.02 |
| 6546 | Left-hemisphere visual network to left-hemisphere visual network white-matter structural connectivity | GCST90302648 | 0.02 |
| 6547 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T499 | ECGA000499 | 0.02 |
| 6548 | Phosphoglycerides levels (UKB data field 23434) | GCST90269531 | 0.02 |
| 6549 | BRK1 levels | GCST90468469 | 0.02 |
| 6550 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T451 | ECGU000451 | 0.02 |
| 6551 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T82 | ECGA000082 | 0.02 |
| 6552 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 3) | GCST90320822 | 0.02 |
| 6553 | T1 FreeSurfer aseg 4th-Ventricle | GCST90384148 | 0.02 |
| 6554 | Cryptic phenotype that captures autosomal dominant polycystic kidney disease severity | GCST90101829 | 0.02 |
| 6555 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T165 | ECGA000165 | 0.02 |
| 6556 | aparc-pial lh area cuneus | GCST90003145 | 0.02 |
| 6557 | APCS levels | GCST90428463 | 0.02 |
| 6558 | Ankle spacing width (right) | Bone-densitometry of heel | UKBB00000034 | 0.02 |
| 6559 | Placental weight (maternal genotype, adjusted for sex and gestational age) | GCST90275190 | 0.02 |
| 6560 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T271 | ECGA000271 | 0.02 |
| 6561 | FVC | GCST90278629 | 0.02 |
| 6562 | CD40 levels | GCST90468633 | 0.02 |
| 6563 | GRAP2/MAP4K5 ratio | GCST90314982 | 0.02 |
| 6564 | Seropositive rheumatoid arthritis, strict definition | FING00001297 | 0.02 |
| 6565 | EDAR/TREML2 ratio | GCST90314592 | 0.02 |
| 6566 | ENO2/HCLS1 ratio | GCST90314660 | 0.02 |
| 6567 | Pulse pressure | GCST90018750 | 0.02 |
| 6568 | aparc-Desikan rh area lateraloccipital | GCST90003117 | 0.02 |
| 6569 | Breast cancer (estrogen-receptor negative) | GCST005076 | 0.02 |
| 6570 | CD27/TGFBR2 ratio | GCST90313776 | 0.02 |
| 6571 | Hippocampal subfield left CA4 volume (head) | GCST90267943 | 0.02 |
| 6572 | Melanocytic naevi, other sites/unspecified | FING00000802 | 0.02 |
| 6573 | Volume of left anterior amygdaloid area | GCST90474871 | 0.02 |
| 6574 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T163 | ECGA000163 | 0.02 |
| 6575 | DDC levels | GCST90468967 | 0.02 |
| 6576 | Diacylglycerol_32:2_[M+H-H2O]1+ levels | GCST90060168 | 0.02 |
| 6577 | Human herpes virus 7 U14 antibody levels | GCST90006909 | 0.02 |
| 6578 | hematocrit (minimum, inv-norm transformed) | GCST90475344 | 0.02 |
| 6579 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 12) | GCST90320831 | 0.02 |
| 6580 | Psoas tendinitis | FING00001221 | 0.02 |
| 6581 | QDPR/THOP1 ratio | GCST90315757 | 0.02 |
| 6582 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T497 | ECGA000497 | 0.02 |
| 6583 | BA-exvivo rh volume V1 | GCST90002858 | 0.02 |
| 6584 | S100A11/SERPINB8 ratio | GCST90315799 | 0.02 |
| 6585 | Phospholipids to total lipids in large LDL percentage (UKB data field 23614) | GCST90269711 | 0.02 |
| 6586 | Age-related macular degeneration | GCST90086111 | 0.02 |
| 6587 | aparc-DKTatlas lh area lingual | GCST90003245 | 0.02 |
| 6588 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90502155 | 0.02 |
| 6589 | Cholecystitis | FING00000274 | 0.02 |
| 6590 | Cancer of prostate (PheCode 185) | GCST90041853 | 0.02 |
| 6591 | aparc-Desikan lh thickness cuneus | GCST90003449 | 0.02 |
| 6592 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T244 | ECGA000244 | 0.02 |
| 6593 | SEMA4D levels | GCST90470573 | 0.02 |
| 6594 | Free cholesterol in large HDL (UKB data field 23563) | GCST90269660 | 0.02 |
| 6595 | Cholesterol to Total Lipids in Small HDL percentage | GCST90499373 | 0.02 |
| 6596 | Enlarged prostate (Benign prostatic hyperplasia) | GCST90475261 | 0.02 |
| 6597 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 3) | GCST90320566 | 0.02 |
| 6598 | GAS6/NOTCH1 ratio | GCST90314918 | 0.02 |
| 6599 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T249 | ECGU000249 | 0.02 |
| 6600 | THBS2 levels | GCST90470854 | 0.02 |
| 6601 | Heart attack | GCST90468132 | 0.02 |
| 6602 | ORM1 levels | GCST90470129 | 0.02 |
| 6603 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T197 | ECGA000197 | 0.02 |
| 6604 | Skin color (cheek, B value) | GCST90502779 | 0.02 |
| 6605 | T1 FreeSurfer BA rh V2 exvivo thickness | GCST90385571 | 0.02 |
| 6606 | Pulse pressure | GCST90301702 | 0.02 |
| 6607 | potassium (minimum, inv-norm transformed) | GCST90476310 | 0.02 |
| 6608 | Facial wrinkles (under eye) | GCST90094903 | 0.02 |
| 6609 | SF3B4/SIRT2 ratio | GCST90315838 | 0.02 |
| 6610 | red cell diameter width (RDW, minimum, inv-norm transformed) | GCST90476365 | 0.02 |
| 6611 | AXIN1/BACH1 ratio | GCST90313400 | 0.02 |
| 6612 | Pregnenetriol sulfate levels | GCST90200241 | 0.02 |
| 6613 | MYOC levels | GCST90422825 | 0.02 |
| 6614 | Disorder of skin and subcutaneous tissue NO (PheCode 689) | GCST90476169 | 0.02 |
| 6615 | Noninfective enteritis and colitis | FING00000881 | 0.02 |
| 6616 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T167 | ECGA000167 | 0.02 |
| 6617 | Benign neoplasm of skin (PheCode 216) | GCST90475620 | 0.02 |
| 6618 | PRKAR1A/SNAP23 ratio | GCST90315728 | 0.02 |
| 6619 | Plasma sulfate of piperine metabolite C18H21NO3 (1)* levels in chronic kidney disease | GCST90266016 | 0.02 |
| 6620 | Diabetic retinopathy (PheCode 250.7) | GCST90475689 | 0.02 |
| 6621 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T86 | ECGA000086 | 0.02 |
| 6622 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T181 | ECGU000181 | 0.02 |
| 6623 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T71 | ECGU000071 | 0.02 |
| 6624 | Fasciitis | musculoskeletal | UKBB00000239 | 0.02 |
| 6625 | IDUA levels | GCST90469508 | 0.02 |
| 6626 | Glaucoma | GCST90018632 | 0.02 |
| 6627 | NTN1 levels | GCST90242047 | 0.02 |
| 6628 | CD8A levels | GCST90468655 | 0.02 |
| 6629 | FYB1/MESD ratio | GCST90314911 | 0.02 |
| 6630 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T160 | ECGU000160 | 0.02 |
| 6631 | aseg rh intensity Putamen | GCST90003784 | 0.02 |
| 6632 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 31) | GCST90320850 | 0.02 |
| 6633 | MGLL/STK4 ratio | GCST90315443 | 0.02 |
| 6634 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T280 | ECGA000280 | 0.02 |
| 6635 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T248 | ECGU000248 | 0.02 |
| 6636 | Myocardial infarction, strict | FING00000852 | 0.02 |
| 6637 | CC2D1A levels | GCST90468557 | 0.02 |
| 6638 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T135 | ECGA000135 | 0.02 |
| 6639 | IL16 levels | GCST90469557 | 0.02 |
| 6640 | PARK7 levels | GCST90470159 | 0.02 |
| 6641 | SMPD3 levels | GCST90470685 | 0.02 |
| 6642 | Triglycerides in medium HDL | GCST90498667 | 0.02 |
| 6643 | Knee extension strength | GCST90319502 | 0.02 |
| 6644 | CD200/CNTNAP2 ratio | GCST90313747 | 0.02 |
| 6645 | Lysoalkenylphosphatidylethanolamine (P-20:0) levels | GCST90025460 | 0.02 |
| 6646 | Polyunsaturated fatty acid levels | GCST90502623 | 0.02 |
| 6647 | Graves disease, strict definition | FING00000592 | 0.02 |
| 6648 | CASP10/ING1 ratio | GCST90313625 | 0.02 |
| 6649 | ENAH levels | GCST90469106 | 0.02 |
| 6650 | Diastolic blood pressure | GCST90310295 | 0.02 |
| 6651 | aparc-pial lh area rostralmiddlefrontal | GCST90003167 | 0.02 |
| 6652 | Sphingomyelin_41:2_[M+H]1+ levels | GCST90060383 | 0.02 |
| 6653 | Monoclonal gammopathy of undetermined significance | GCST90624745 | 0.02 |
| 6654 | Hippocampal right GC-ML-DG volume (head) | GCST90267968 | 0.02 |
| 6655 | Free Cholesterol to Total Lipids in Medium VLDL percentage | GCST90498988 | 0.02 |
| 6656 | aparc-a2009s rh area G-cuneus | GCST90003381 | 0.02 |
| 6657 | Hematocrit | GCST90278634 | 0.02 |
| 6658 | IDP dMRI TBSS ISOVF Posterior corona radiata R | GCST90004503 | 0.02 |
| 6659 | BA-exvivo lh volume V2 | GCST90002845 | 0.02 |
| 6660 | TACC3/TRIAP1 ratio | GCST90315901 | 0.02 |
| 6661 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 128) | GCST90320691 | 0.02 |
| 6662 | Dronedarone medication | FING00000474 | 0.02 |
| 6663 | DBN1 levels | GCST90468950 | 0.02 |
| 6664 | TNFRSF8 levels | GCST90470915 | 0.02 |
| 6665 | DCTN1/ERBIN ratio | GCST90314429 | 0.02 |
| 6666 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T26 | ECGA000026 | 0.02 |
| 6667 | LIPF levels | GCST90469780 | 0.02 |
| 6668 | DTI TBSS MD Posterior limb of internal capsule R | GCST90384590 | 0.02 |
| 6669 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T145 | ECGA000145 | 0.02 |
| 6670 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 26) | GCST90320845 | 0.02 |
| 6671 | Alzheimer's disease (late onset) | GCST002245 | 0.02 |
| 6672 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T246 | ECGU000246 | 0.02 |
| 6673 | UROD levels | GCST90471016 | 0.02 |
| 6674 | Treatment/medication code - seretide 50 evohaler | Medications | UKBB00000858 | 0.02 |
| 6675 | Whole body fat-free mass | Impedance measures | UKBB00000915 | 0.02 |
| 6676 | SOD1 levels | GCST90470704 | 0.02 |
| 6677 | Benign neoplasm of major salivary glands | FING00000157 | 0.02 |
| 6678 | LGALS3 levels | GCST90012009 | 0.02 |
| 6679 | DHX58 levels | GCST90618238 | 0.02 |
| 6680 | CLEC4G/NELL2 ratio | GCST90314122 | 0.02 |
| 6681 | Sitting height | Body size measures | UKBB00000771 | 0.02 |
| 6682 | Triglyceride to phosphoglyceride ratio | GCST90499996 | 0.02 |
| 6683 | Percentage of FA2G1 in total neutral plasma glycans (GPn) (GP61) | GCST90668739 | 0.02 |
| 6684 | ANGPT1/SERPINE1 ratio | GCST90313269 | 0.02 |
| 6685 | CD300LG/TNFRSF1A ratio | GCST90313803 | 0.02 |
| 6686 | Phosphatidylcholine_34:1_[M+H]1+/Phosphatidylethanolamine_37:1_[M+H]1+/Phosphatidate_39:2_[M+NH4]1+ levels | GCST90060307 | 0.02 |
| 6687 | NSFL1C/UBAC1 ratio | GCST90315565 | 0.02 |
| 6688 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T159 | ECGU000159 | 0.02 |
| 6689 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T466 | ECGU000466 | 0.02 |
| 6690 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T13 | ECGA000013 | 0.02 |
| 6691 | LEFTY2 levels | GCST90469752 | 0.02 |
| 6692 | DTI autoptx L3 ptr r tract | GCST90385213 | 0.02 |
| 6693 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T246 | ECGA000246 | 0.02 |
| 6694 | DTI autoptx L2 ptr r tract | GCST90385186 | 0.02 |
| 6695 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 11) | GCST90320574 | 0.02 |
| 6696 | Urine glycine conjugate of C10H14O2 (1)* levels in chronic kidney disease | GCST90265274 | 0.02 |
| 6697 | ARHGAP25/RNF41 ratio | GCST90313345 | 0.02 |
| 6698 | CCDC80/CHRDL1 ratio | GCST90313670 | 0.02 |
| 6699 | Cervical disc disorders | FING00000265 | 0.02 |
| 6700 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T250 | ECGU000250 | 0.02 |
| 6701 | Thyroxine levels | GCST90200293 | 0.02 |
| 6702 | IDP dMRI TBSS MD Corticospinal tract R | GCST90004033 | 0.02 |
| 6703 | IDP dMRI TBSS L2 Retrolenticular part of internal capsule R | GCST90004143 | 0.02 |
| 6704 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T268 | ECGU000268 | 0.02 |
| 6705 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T155 | ECGA000155 | 0.02 |
| 6706 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 22) | GCST90320841 | 0.02 |
| 6707 | SSC4D levels | GCST90470747 | 0.02 |
| 6708 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 86) | GCST90320649 | 0.02 |
| 6709 | Cerebrospinal fluid unidentified metabolite levels (HILIC Metabolomics ID: 7.99_210.09) | GCST90291312 | 0.02 |
| 6710 | Arterial embolism and thrombosis of lower extremity artery | FING00000106 | 0.02 |
| 6711 | AMY2A levels | GCST90468298 | 0.02 |
| 6712 | potassium (mean, inv-norm transformed) | GCST90476307 | 0.02 |
| 6713 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T125 | ECGA000125 | 0.02 |
| 6714 | Mean corpuscular hemoglobin concentration | GCST90002391 | 0.02 |
| 6715 | Other cataract | FING00000976 | 0.02 |
| 6716 | Transient ischemic attack | FING00001375 | 0.02 |
| 6717 | Phenylacetate levels | GCST90199630 | 0.02 |
| 6718 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T245 | ECGU000245 | 0.02 |
| 6719 | IDP dMRI TBSS MD Anterior limb of internal capsule R | GCST90004043 | 0.02 |
| 6720 | Triglycerides in small VLDL | GCST90499917 | 0.02 |
| 6721 | Corneal resistance factor | GCST90308682 | 0.02 |
| 6722 | Rheumatoid arthritis | GCST90018690 | 0.02 |
| 6723 | Liver enzyme levels (alkaline phosphatase) | GCST90013406 | 0.02 |
| 6724 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T252 | ECGU000252 | 0.02 |
| 6725 | Hair/balding pattern: Pattern 1 (UKB data field 2395_1) | GCST90043616 | 0.02 |
| 6726 | DCXR levels | GCST90468964 | 0.02 |
| 6727 | Chronic renal failure [CKD] (PheCode 585.3) | GCST90476123 | 0.02 |
| 6728 | VCAN levels | GCST90471032 | 0.02 |
| 6729 | Hypothyroidism (PheCode 244) | GCST90475647 | 0.02 |
| 6730 | C2 levels | GCST90468497 | 0.02 |
| 6731 | SRC/TBL1X ratio | GCST90315884 | 0.01 |
| 6732 | Other disorders of testis (PheCode 603) | GCST90476156 | 0.01 |
| 6733 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T179 | ECGU000179 | 0.01 |
| 6734 | AREG levels | GCST90468347 | 0.01 |
| 6735 | IDP dMRI ProbtrackX L2 cst l | GCST90004281 | 0.01 |
| 6736 | ALCAM/ENPP2 ratio | GCST90313236 | 0.01 |
| 6737 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 44) | GCST90320607 | 0.01 |
| 6738 | Free cholesterol in very large HDL (UKB data field 23556) | GCST90269653 | 0.01 |
| 6739 | IDP dMRI TBSS OD Tapetum R | GCST90004448 | 0.01 |
| 6740 | Cholesterol levels in very small VLDL | GCST90500700 | 0.01 |
| 6741 | ENO2/MANF ratio | GCST90314662 | 0.01 |
| 6742 | RBKS levels | GCST90470433 | 0.01 |
| 6743 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 90) | GCST90320909 | 0.01 |
| 6744 | CD209/CLEC4G ratio | GCST90313750 | 0.01 |
| 6745 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T180 | ECGU000180 | 0.01 |
| 6746 | Non-insulin-dependent diabetes mellitus | Diabetes mellitus | UKBB00000524 | 0.01 |
| 6747 | RNASET2 levels | GCST90470481 | 0.01 |
| 6748 | Macular degeneration, dry (PheCode 362.21) | GCST90475851 | 0.01 |
| 6749 | 5alpha-pregnan-3beta,20beta-diol monosulfate (1) levels | GCST90199853 | 0.01 |
| 6750 | Acylcarnitine (18:2) levels | GCST90024623 | 0.01 |
| 6751 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T5 | ECGA000005 | 0.01 |
| 6752 | aparc-DKTatlas lh volume insula | GCST90002893 | 0.01 |
| 6753 | Inguinal hernia | FING00000681 | 0.01 |
| 6754 | DIABLO/GRAP2 ratio | GCST90314466 | 0.01 |
| 6755 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T175 | ECGA000175 | 0.01 |
| 6756 | Ankle spacing width (left) | Bone-densitometry of heel | UKBB00000033 | 0.01 |
| 6757 | Incidence of bisecting GlcNAc in all fucosylated disialylated structures (GP57) | GCST90668735 | 0.01 |
| 6758 | Dry age-related macular degeneration (includes geographic atrophy) | FING00000480 | 0.01 |
| 6759 | Diverticulosis (PheCode 562.1) | GCST90476076 | 0.01 |
| 6760 | Degenerative skin conditions and other dermatoses (PheCode 702) | GCST90476202 | 0.01 |
| 6761 | CTRC/PLA2G1B ratio | GCST90314310 | 0.01 |
| 6762 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T265 | ECGA000265 | 0.01 |
| 6763 | Non-HDL cholesterol levels | GCST90239669 | 0.01 |
| 6764 | Hypothyroidism | GCST90319320 | 0.01 |
| 6765 | Chronic Kidney Disease, Stage III (PheCode 585.33) | GCST90476128 | 0.01 |
| 6766 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T247 | ECGU000247 | 0.01 |
| 6767 | HTRA2/SIAE ratio | GCST90315097 | 0.01 |
| 6768 | Red cell distribution width | GCST006804 | 0.01 |
| 6769 | IL1R1 levels | GCST90425563 | 0.01 |
| 6770 | MSMB levels | GCST90469949 | 0.01 |
| 6771 | Hip index | GCST012229 | 0.01 |
| 6772 | Colorectal cancer (PheCode 153) | GCST90475566 | 0.01 |
| 6773 | MS-disease / Multiple Sclerosis | FING00000839 | 0.01 |
| 6774 | Fibroblastic disorders | Other soft tissue disorders | UKBB00000246 | 0.01 |
| 6775 | Keratitis | FING00000708 | 0.01 |
| 6776 | Triglycerides to Total Lipids in Small HDL percentage | GCST90499543 | 0.01 |
| 6777 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T269 | ECGU000269 | 0.01 |
| 6778 | Bicarbonate (minimum, inv-norm transformed) | GCST90475150 | 0.01 |
| 6779 | ACY1/SCLY ratio | GCST90313165 | 0.01 |
| 6780 | Corns and callosities (PheCode 700) | GCST90476196 | 0.01 |
| 6781 | T1 FreeSurfer DKT rh lateraloccipital area | GCST90384295 | 0.01 |
| 6782 | Hip circumference adjusted for BMI | GCST90020028 | 0.01 |
| 6783 | Sulcal opening distance of the right calloso-marginal posterior fissure | GCST90104946 | 0.01 |
| 6784 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 108) | GCST90320927 | 0.01 |
| 6785 | Phosphoglycerides levels | GCST90092938 | 0.01 |
| 6786 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T176 | ECGA000176 | 0.01 |
| 6787 | Cancer | GCST90086052 | 0.01 |
| 6788 | Skin cancer | GCST90475575 | 0.01 |
| 6789 | ATP5IF1/METAP1D ratio | GCST90313391 | 0.01 |
| 6790 | ASAH2 levels | GCST90468374 | 0.01 |
| 6791 | CST6/NECTIN4 ratio | GCST90314303 | 0.01 |
| 6792 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T166 | ECGA000166 | 0.01 |
| 6793 | SRSF7 levels | GCST90242771 | 0.01 |
| 6794 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T143 | ECGA000143 | 0.01 |
| 6795 | CCN2/TPP1 ratio | GCST90313718 | 0.01 |
| 6796 | ACE2/MME ratio | GCST90313154 | 0.01 |
| 6797 | Prostate cancer | GCST90018685 | 0.01 |
| 6798 | Cholesteryl Esters in Small LDL | GCST90499578 | 0.01 |
| 6799 | Glycated hemoglobin levels | GCST90002243 | 0.01 |
| 6800 | Ventral hernia | FING00001428 | 0.01 |
| 6801 | Acquired foot deformities (PheCode 735) | GCST90476247 | 0.01 |
| 6802 | Basal cell carcinoma (MTAG) | GCST90137411 | 0.01 |
| 6803 | DBNL/HSPA1A ratio | GCST90314418 | 0.01 |
| 6804 | USP8 levels | GCST90471022 | 0.01 |
| 6805 | aparc-Desikan rh area parsopercularis | GCST90003124 | 0.01 |
| 6806 | Carboplatin drug response (IC50) | GCST90011783 | 0.01 |
| 6807 | Degree of unsaturation | GCST90502230 | 0.01 |
| 6808 | Abnormal results of function study of thyro (PheCode 246.7) | GCST90475654 | 0.01 |
| 6809 | CD58/TYRO3 ratio | GCST90313856 | 0.01 |
| 6810 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T216 | ECGU000216 | 0.01 |
| 6811 | Treatment or medication use - metformin (UKB data field 20003_1140884600) | GCST90042245 | 0.01 |
| 6812 | TBC1D23 levels | GCST90470810 | 0.01 |
| 6813 | Retention of urine | FING00001257 | 0.01 |
| 6814 | CRIM1/NRP2 ratio | GCST90314261 | 0.01 |
| 6815 | Gout | GCST90399701 | 0.01 |
| 6816 | SMTN levels | GCST90470689 | 0.01 |
| 6817 | Hair colour (natural, before greying) - Black | Sun exposure | UKBB00000295 | 0.01 |
| 6818 | MTHFSD levels | GCST90469956 | 0.01 |
| 6819 | Waist circumference adjusted for body mass index | GCST012226 | 0.01 |
| 6820 | Glycine levels | GCST90497315 | 0.01 |
| 6821 | ALPP levels | GCST90468286 | 0.01 |
| 6822 | MSRA/SNAP29 ratio | GCST90315500 | 0.01 |
| 6823 | Triglycerides in medium HDL | GCST90498672 | 0.01 |
| 6824 | BAG3 levels | GCST90468416 | 0.01 |
| 6825 | Ectopic pregnancy | FING00000487 | 0.01 |
| 6826 | Triglycerides in IDL | GCST90497671 | 0.01 |
| 6827 | Retinal venular width | GCST90270400 | 0.01 |
| 6828 | IDP dMRI TBSS FA Cerebral peduncle R | GCST90003891 | 0.01 |
| 6829 | COL1A1/SOST ratio | GCST90314172 | 0.01 |
| 6830 | PLA2G1B levels | GCST90470246 | 0.01 |
| 6831 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T149 | ECGA000149 | 0.01 |
| 6832 | EPHB4 levels | GCST90469132 | 0.01 |
| 6833 | Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - Hayfever, allergic rhinitis or eczema | Medical conditions | UKBB00000100 | 0.01 |
| 6834 | Glaucoma (multi-trait analysis) | GCST009722 | 0.01 |
| 6835 | KIRREL2/PLA2G1B ratio | GCST90315251 | 0.01 |
| 6836 | DTI autoptx FA ifo l tract | GCST90385124 | 0.01 |
| 6837 | Ulcerative rectosigmoiditis | FING00001394 | 0.01 |
| 6838 | Histidine levels | GCST90497479 | 0.01 |
| 6839 | Contracture of palmar fascia [Dupuytren's disease] | musculoskeletal | UKBB00000146 | 0.01 |
| 6840 | Blood cell traits latent factor 2 (red cell) | GCST90559244 | 0.01 |
| 6841 | NRCAM/PCDH17 ratio | GCST90315553 | 0.01 |
| 6842 | Emphysema | FING00000496 | 0.01 |
| 6843 | Ratio of polyunsaturated fatty acids to total fatty acids | GCST90092941 | 0.01 |
| 6844 | PDE5A levels | GCST90470187 | 0.01 |
| 6845 | Prostate cancer | GCST006085 | 0.01 |
| 6846 | REST UKBBICA NET100 1111 | GCST90386965 | 0.01 |
| 6847 | COL6A3/OGN ratio | GCST90314177 | 0.01 |
| 6848 | Volume of left paralaminar nucleus | GCST90474895 | 0.01 |
| 6849 | 1-stearoyl-2-arachidonoyl-GPC (18:0/20:4) metabolite level | GCST90615670 | 0.01 |
| 6850 | Hypothyroidism | GCST90204167 | 0.01 |
| 6851 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T82 | ECGU000082 | 0.01 |
| 6852 | wg rh intensity-contrast lateralorbitofrontal | GCST90003838 | 0.01 |
| 6853 | Breast size | GCST006655 | 0.01 |
| 6854 | IDP T1 FAST ROIs R planum temporale | GCST90002542 | 0.01 |
| 6855 | HNMT levels | GCST90469468 | 0.01 |
| 6856 | Cardiometabolic multimorbidity | GCST90274723 | 0.01 |
| 6857 | DTI TBSS L3 Anterior corona radiata R | GCST90384546 | 0.01 |
| 6858 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T245 | ECGA000245 | 0.01 |
| 6859 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T143 | ECGU000143 | 0.01 |
| 6860 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 124) | GCST90320943 | 0.01 |
| 6861 | ITGB1BP2/USP8 ratio | GCST90315223 | 0.01 |
| 6862 | Mild age-related type 2 diabetes | GCST90026416 | 0.01 |
| 6863 | IDP dMRI ProbtrackX L3 ar r | GCST90004301 | 0.01 |
| 6864 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T272 | ECGA000272 | 0.01 |
| 6865 | DPT levels | GCST90469036 | 0.01 |
| 6866 | TSHB levels | GCST90470974 | 0.01 |
| 6867 | Whole body water mass | Impedance measures | UKBB00000916 | 0.01 |
| 6868 | CEACAM1/GGT1 ratio | GCST90314000 | 0.01 |
| 6869 | PCDH12 levels | GCST90470168 | 0.01 |
| 6870 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T474 | ECGU000474 | 0.01 |
| 6871 | aparc-DKTatlas rh volume parstriangularis | GCST90002911 | 0.01 |
| 6872 | Hippocampal left GC-ML-DG volume (head) | GCST90267946 | 0.01 |
| 6873 | Cis-4-decenoylcarnitine (C10:1) metabolite level | GCST90615729 | 0.01 |
| 6874 | Thyroid stimulating hormone levels | GCST90296333 | 0.01 |
| 6875 | Intra-ocular pressure, Goldmann-correlated (right) | Intraocular pressure | UKBB00000377 | 0.01 |
| 6876 | Triglycerides | Blood biochemistry | UKBB00000861 | 0.01 |
| 6877 | Rectal cancer | GCST90011810 | 0.01 |
| 6878 | Polycythemia, secondary (PheCode 289.8) | GCST90475822 | 0.01 |
| 6879 | Mean corpuscular haemoglobin concentration (UKB data field 30060) | GCST90468085 | 0.01 |
| 6880 | BAIAP2/MME ratio | GCST90313453 | 0.01 |
| 6881 | GRPEL1 levels | GCST90469405 | 0.01 |
| 6882 | Cholesteryl esters in very large VLDL | GCST90500552 | 0.01 |
| 6883 | Pregnenediol sulfate (C21H34O5S) levels | GCST90199861 | 0.01 |
| 6884 | Calculus of lower urinary tract | FING00000237 | 0.01 |
| 6885 | CD244/EDAR ratio | GCST90313764 | 0.01 |
| 6886 | DIABLO levels | GCST90468994 | 0.01 |
| 6887 | Acquired hypothyroidism (PheCode 244.2) | GCST90475650 | 0.01 |
| 6888 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T134 | ECGA000134 | 0.01 |
| 6889 | PARP1/TCL1A ratio | GCST90315602 | 0.01 |
| 6890 | Degree of unsaturation | GCST90502753 | 0.01 |
| 6891 | Other localized connective tissue disorders | FING00001066 | 0.01 |
| 6892 | Forced vital capacity FVC Z score (UKB data field 20257) | GCST90468167 | 0.01 |
| 6893 | Cancer (UKB data field 2453) | GCST90043628 | 0.01 |
| 6894 | DTI TBSS MD Superior fronto-occipital fasciculus R | GCST90384614 | 0.01 |
| 6895 | Estimated glomerular filtration rate, cystain C | Other measurement | UKBB00000210 | 0.01 |
| 6896 | aparc-DKTatlas rh volume lateraloccipital | GCST90002902 | 0.01 |
| 6897 | Allergic conjunctivitis | FING00000067 | 0.01 |
| 6898 | Triglycerides in small HDL | GCST90499516 | 0.01 |
| 6899 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T15 | ECGU000015 | 0.01 |
| 6900 | FURIN/IGSF3 ratio | GCST90314885 | 0.01 |
| 6901 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T251 | ECGU000251 | 0.01 |
| 6902 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T480 | ECGU000480 | 0.01 |
| 6903 | Endometriosis of ovary | FING00000501 | 0.01 |
| 6904 | Primary open angle glaucoma (PheCode 365.11) | GCST90475875 | 0.01 |
| 6905 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T263 | ECGU000263 | 0.01 |
| 6906 | Kidney volume | GCST90016670 | 0.01 |
| 6907 | Autoimmune hyperthyroidism | FING00000134 | 0.01 |
| 6908 | CABP2 levels | GCST90468519 | 0.01 |
| 6909 | hemoglobin (minimum, inv-norm transformed) | GCST90475380 | 0.01 |
| 6910 | MANF/PRDX5 ratio | GCST90315365 | 0.01 |
| 6911 | Volume of left whole amygdala | GCST90474988 | 0.01 |
| 6912 | Takes medication for Sleep apnea? | GCST90475258 | 0.01 |
| 6913 | 5alpha-pregnan-3beta,20alpha-diol disulfate levels | GCST90199838 | 0.01 |
| 6914 | Hypothyroidism NOS (PheCode 244.4) | GCST90475653 | 0.01 |
| 6915 | DTI TBSS MD Anterior limb of internal capsule L | GCST90384589 | 0.01 |
| 6916 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T150 | ECGA000150 | 0.01 |
| 6917 | CASP8/SEPTIN9 ratio | GCST90313658 | 0.01 |
| 6918 | IDP SWI T2star left putamen | GCST90003867 | 0.01 |
| 6919 | wg lh intensity-contrast entorhinal | GCST90003797 | 0.01 |
| 6920 | T1 CAT volume R InsularCortex | GCST90384003 | 0.01 |
| 6921 | BCR/ITGB1BP2 ratio | GCST90313494 | 0.01 |
| 6922 | Hallux valgus (Bunion) | musculoskeletal | UKBB00000299 | 0.01 |
| 6923 | CXCL11 levels | GCST90274781 | 0.01 |
| 6924 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T471 | ECGU000471 | 0.01 |
| 6925 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T461 | ECGU000461 | 0.01 |
| 6926 | Vanillactate levels | GCST90199978 | 0.01 |
| 6927 | IDP T1 FAST ROIs L hippocampus | GCST90002555 | 0.01 |
| 6928 | Forced vital capacity (FVC) | Spirometry | UKBB00000254 | 0.01 |
| 6929 | Calculus of ureter (PheCode 594.3) | GCST90476147 | 0.01 |
| 6930 | ITGB1BP2/STAT5B ratio | GCST90315220 | 0.01 |
| 6931 | Deep venous thrombosis | GCST90468122 | 0.01 |
| 6932 | T1 FreeSurfer DK rh cuneus volume | GCST90385761 | 0.01 |
| 6933 | F2R/ITGB1BP2 ratio | GCST90314731 | 0.01 |
| 6934 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T279 | ECGA000279 | 0.01 |
| 6935 | SPESP1 levels | GCST90470720 | 0.01 |
| 6936 | Volume of left cortical nucleus | GCST90474886 | 0.01 |
| 6937 | Pulse pressure | GCST90301701 | 0.01 |
| 6938 | Glaucoma | FING00000577 | 0.01 |
| 6939 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T12 | ECGU000012 | 0.01 |
| 6940 | GLB1/PCSK9 ratio | GCST90314933 | 0.01 |
| 6941 | Delta body mass index (difference between ECG-predicted and measured) | GCST90429062 | 0.01 |
| 6942 | Hernia of abdominal wall | FING00000617 | 0.01 |
| 6943 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T247 | ECGA000247 | 0.01 |
| 6944 | GKN2 levels | GCST90089413 | 0.01 |
| 6945 | CCL20 levels | GCST90012077 | 0.01 |
| 6946 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T21 | ECGA000021 | 0.01 |
| 6947 | IGFBP2 levels | GCST90469528 | 0.01 |
| 6948 | ROR1/THBD ratio | GCST90315786 | 0.01 |
| 6949 | Forced expiratory volume in 1 second FEV1 Z score (UKB data field 20256) | GCST90468166 | 0.01 |
| 6950 | Endometriosis | GCST90018619 | 0.01 |
| 6951 | DBI/TMSB10 ratio | GCST90314414 | 0.01 |
| 6952 | NPY/SMOC1 ratio | GCST90315551 | 0.01 |
| 6953 | Phosphatidylethanolamine (18:0_18:1) levels | GCST90024977 | 0.01 |
| 6954 | NUCB2/RSPO3 ratio | GCST90315575 | 0.01 |
| 6955 | Free cholesterol in large LDL | GCST90497981 | 0.01 |
| 6956 | PCSK9 levels | GCST90428110 | 0.01 |
| 6957 | Phospholipid levels in very small VLDL | GCST90093036 | 0.01 |
| 6958 | Facial skin colour (CIELAB index b* value) | GCST90020056 | 0.01 |
| 6959 | Volume of right paralaminar nucleus | GCST90475048 | 0.01 |
| 6960 | RIDA levels | GCST90470469 | 0.01 |
| 6961 | aparc-pial rh area parsopercularis | GCST90003191 | 0.01 |
| 6962 | CPXM1/VEGFC ratio | GCST90314223 | 0.01 |
| 6963 | Lifespan | GCST90551886 | 0.01 |
| 6964 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 72) | GCST90320891 | 0.01 |
| 6965 | wg rh intensity-contrast lateraloccipital | GCST90003837 | 0.01 |
| 6966 | Free cholesterol levels in medium HDL | GCST90132679 | 0.01 |
| 6967 | Interpolated Age of participant when operation took place | Operations | UKBB00000370 | 0.01 |
| 6968 | MMP12 levels | GCST90012070 | 0.01 |
| 6969 | IFNLR1 levels | GCST90469518 | 0.01 |
| 6970 | IDP dMRI TBSS FA Uncinate fasciculus R | GCST90003921 | 0.01 |
| 6971 | DPP6 levels | GCST90469034 | 0.01 |
| 6972 | Takes medication for gout? | GCST90476382 | 0.01 |
| 6973 | CLMP/TGFBR2 ratio | GCST90314135 | 0.01 |
| 6974 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T36 | ECGA000036 | 0.01 |
| 6975 | AHSP/BLVRB ratio | GCST90313214 | 0.01 |
| 6976 | TCL1A levels | GCST90470817 | 0.01 |
| 6977 | EPO levels | GCST90469136 | 0.01 |
| 6978 | CD63/EDAR ratio | GCST90313864 | 0.01 |
| 6979 | DTI TBSS MD Posterior limb of internal capsule L | GCST90384591 | 0.01 |
| 6980 | Cysteine-glutathione disulfide levels | GCST90199784 | 0.01 |
| 6981 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T127 | ECGA000127 | 0.01 |
| 6982 | Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8 (more control exclusions) | FING00000694 | 0.01 |
| 6983 | DNAJA2/SCAMP3 ratio | GCST90314507 | 0.01 |
| 6984 | Pancreas iron content | GCST90016676 | 0.01 |
| 6985 | Nasal polyp | FING00000858 | 0.01 |
| 6986 | TYMP levels | GCST90470996 | 0.01 |
| 6987 | Blood cell traits latent factor 20 (red cell) | GCST90559262 | 0.01 |
| 6988 | AMOT levels | GCST90468295 | 0.01 |
| 6989 | CD83/TREM2 ratio | GCST90313908 | 0.01 |
| 6990 | MRPL33 levels | GCST90617986 | 0.01 |
| 6991 | GPA33 levels | GCST90469385 | 0.01 |
| 6992 | PDZK1 levels | GCST90470203 | 0.01 |
| 6993 | Polyunsaturated fatty acids to total fatty acids percentage | GCST90502632 | 0.01 |
| 6994 | Graves' disease (PheCode 242.1) | GCST90475644 | 0.01 |
| 6995 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 127) | GCST90320690 | 0.01 |
| 6996 | Glaucoma suspect | FING00000579 | 0.01 |
| 6997 | Bacterial pneumoniae | FING00000139 | 0.01 |
| 6998 | Gestational [pregnancy-induced] oedema and proteinuria without hypertension | FING00000572 | 0.01 |
| 6999 | Triglycerides in small HDL | GCST90499519 | 0.01 |
| 7000 | CD209/CLEC14A ratio | GCST90313749 | 0.01 |